JB Chemicals receives ANDA approval for Loratadine Tablets USP for OTC use

The Company expects to commercialize this product in Ql of FY 2021-22 and is expected to improve Company's US sales.

Jan 08, 2021 04:01 IST India Infoline News Service

J.B. Chemicals & Pharmaceuticals announced that US FDA has approved Company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg (for treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy) for over-the-counter (OTC) use.

This product is generic version of Clartin tablet in the same strength of Bayer Healthcare LLC.

The Company expects to commercialize this product in Ql of FY 2021-22 and is expected to improve Company's US sales.

J B Chemicals & Pharmaceuticals ended at Rs1,051.80 per piece up by Rs16.85 or 1.63% from its previous closing of Rs1,034.95 on the BSE.

Related Story

Open Free Demat Account (Rs699)